Evidence map›Paper›PMID 36139020›Full record

ArticleBiomolecules2022

The Pro-Fibrotic Response to Lens Injury Is Signaled in a PI3K Isoform-Specific Manner.

A Sue Menko, Janice L Walker

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

A Sue MenkoDepartment of Pathology, Anatomy and Cell Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.ORCID 0000-0002-7514-4696
Janice L WalkerDepartment of Pathology, Anatomy and Cell Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Thomas Jefferson University · US

Funding

Paradigms of Wound Healing and Fibrosis in the EyeR01EY021784 · NEI · THOMAS JEFFERSON UNIVERSITY · PI A. Sue Menko, Mary Ann Stepp · 2011 to 2026
$7.3M
Structure of post-replicative chromatin during cell reprogramming in fibrotic diseaseR01EY026159 · NEI · THOMAS JEFFERSON UNIVERSITY · PI MAZO, ALEXANDER M, WALKER, JANICE LYNN · 2017 to 2020
$1.6M
NEI NIH HHS EY021784NEI NIH HHS EY026159NEI NIH HHS R01 EY021784NEI NIH HHS R01 EY026159
6 · The paper itself

Abstract

The signaling inputs that function to integrate biochemical and mechanical cues from the extracellular environment to alter the wound-repair outcome to a fibrotic response remain poorly understood. Here, using a clinically relevant post-cataract surgery wound healing/fibrosis model, we investigated the role of Phosphoinositide-3-kinase (PI3K) class I isoforms as potential signaling integrators to promote the proliferation, emergence and persistence of collagen I-producing alpha smooth muscle actin (αSMA+) myofibroblasts that cause organ fibrosis. Using PI3K isoform specific small molecule inhibitors, our studies revealed a requisite role for PI3K p110α in signaling the CD44+ mesenchymal leader cell population that we previously identified as resident immune cells to produce and organize a fibronectin-EDA rich provisional matrix and transition to collagen I-producing αSMA+ myofibroblasts. While the PI3K effector Akt was alone insufficient to regulate myofibroblast differentiation, our studies revealed a role for Rac, another potential PI3K effector, in this process. Our studies further uncovered a critical role for PI3K p110α in signaling the proliferation of CD44+ leader cells, which is important to the emergence and expansion of myofibroblasts. Thus, these studies identify activation of PI3K p110α as a critical signaling input following wounding to the development and progression of fibrotic disease.

Indexed as

ActinsFibronectinsCollagenFibrosisHumansPhosphatidylinositol 3-KinasePhosphatidylinositol 3-KinasesPhosphatidylinositolsProtein IsoformsProto-Oncogene Proteins c-aktActinsCollagenFibronectinsPhosphatidylinositol 3-KinasePhosphatidylinositol 3-KinasesPhosphatidylinositolsProtein IsoformsProto-Oncogene Proteins c-aktfibrosislensmyofibroblastPI3KPI3Kp110αproliferation

Identifiers

PMID36139020
PMCPMC9496593
OpenAlexW4293106411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.